1 Introduction
1.1 Objective of the study
1.2 Market Definition and Scope of the study
1.3 Markets Covered
1.4 Stakeholders
2 Research Methodology
2.1 INTEGRATED ECOSYSTEM OF DNA MICROARRAY
2.2 ARRIVING AT DNA MICROARRAY MARKET SIZE
2.3 TOP DOWN APPROACH
2.4 BOTTOM-UP APPROACH
2.5 DEMAND (CONSUMPTION) SIDE ANALYSIS
2.6 Macro indicators
2.7 Assumptions
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 PARENT MARKET COMPARISON
4.3 DRIVERS AND INHIBITORS FOR DNA MICROARRAY MARKET
4.4 DEMAND SIDE ANALYSIS
4.5 VENDOR SIDE ANALYSIS
5 DNA Microarray-North America, By Applications
5.1 Split By Geography
5.1 DNA Microarray-U.S. by Applications
5.1 DNA Microarray-Canada by Applications
5.1 DNA Microarray-Mexico by Applications
5.2 DNA Microarray-North America-In Vitro Diagnostics
5.2.1 DNA Microarray-North America-In Vitro Diagnostics, By Geographies
5.2.1.1 DNA Microarray-U.S.-In Vitro Diagnostics
5.2.1.2 DNA Microarray-Canada-In Vitro Diagnostics
5.2.1.3 DNA Microarray-Mexico-In Vitro Diagnostics
5.2.2 DNA Microarray-North America-In Vitro Diagnostics, By Technologies
5.2.2.1 Oligonucleotide Based Gene Chip-North America-In Vitro Diagnostics
5.2.2.2 Complimentary DNA Chips-North America-In Vitro Diagnostics
5.2.3 DNA Microarray-North America-In Vitro Diagnostics, By Products
5.2.3.1 DNA Microarray Instruments-North America-In Vitro Diagnostics
5.2.3.2 DNA Microarray Reagents-North America-In Vitro Diagnostics
5.2.3.3 DNA Microarray Services-North America-In Vitro Diagnostics
5.3 DNA Microarray-North America-Drug Discovery
5.3.1 DNA Microarray-North America-Drug Discovery, By Geographies
5.3.1.1 DNA Microarray-U.S.-Drug Discovery
5.3.1.2 DNA Microarray-Canada-Drug Discovery
5.3.1.3 DNA Microarray-Mexico-Drug Discovery
5.3.2 DNA Microarray-North America-Drug Discovery, By Technologies
5.3.2.1 Oligonucleotide Based Gene Chip-North America-Drug Discovery
5.3.2.2 Complimentary DNA Chips-North America-Drug Discovery
5.3.3 DNA Microarray-North America-Drug Discovery, By Products
5.3.3.1 DNA Microarray Instruments-North America-Drug Discovery
5.3.3.2 DNA Microarray Reagents-North America-Drug Discovery
5.3.3.3 DNA Microarray Services-North America-Drug Discovery
5.4 DNA Microarray-North America-Academics
5.4.1 DNA Microarray-North America-Academics, By Geographies
5.4.1.1 DNA Microarray-U.S.-Academics
5.4.1.2 DNA Microarray-Canada-Academics
5.4.1.3 DNA Microarray-Mexico-Academics
5.4.2 DNA Microarray-North America-Academics, By Technologies
5.4.2.1 Oligonucleotide Based Gene Chip-North America-Academics
5.4.2.2 Complimentary DNA Chips-North America-Academics
5.4.3 DNA Microarray-North America-Academics, By Products
5.4.3.1 DNA Microarray Instruments-North America-Academics
5.4.3.2 DNA Microarray Reagents-North America-Academics
5.4.3.3 DNA Microarray Services-North America-Academics
5.5 DNA Microarray-North America-Agrigenomics
5.5.1 DNA Microarray-North America-Agrigenomics, By Geographies
5.5.1.1 DNA Microarray-U.S.-Agrigenomics
5.5.1.2 DNA Microarray-Canada-Agrigenomics
5.5.1.3 DNA Microarray-Mexico-Agrigenomics
5.5.2 DNA Microarray-North America-Agrigenomics, By Technologies
5.5.2.1 Oligonucleotide Based Gene Chip-North America-Agrigenomics
5.5.2.2 Complimentary DNA Chips-North America-Agrigenomics
5.5.3 DNA Microarray-North America-Agrigenomics, By Products
5.5.3.1 DNA Microarray Instruments-North America-Agrigenomics
5.5.3.2 DNA Microarray Reagents-North America-Agrigenomics
5.5.3.3 DNA Microarray Services-North America-Agrigenomics
5.6 DNA Microarray-North America-Personalized Medicine
5.6.1 DNA Microarray-North America-Personalized Medicine, By Geographies
5.6.1.1 DNA Microarray-U.S.-Personalized Medicine
5.6.1.2 DNA Microarray-Canada-Personalized Medicine
5.6.1.3 DNA Microarray-Mexico-Personalized Medicine
5.6.2 DNA Microarray-North America-Personalized Medicine, By Technologies
5.6.2.1 Oligonucleotide Based Gene Chip-North America-Personalized Medicine
5.6.2.2 Complimentary DNA Chips-North America-Personalized Medicine
5.6.3 DNA Microarray-North America-Personalized Medicine, By Products
5.6.3.1 DNA Microarray Instruments-North America-Personalized Medicine
5.6.3.2 DNA Microarray Reagents-North America-Personalized Medicine
5.6.3.3 DNA Microarray Services-North America-Personalized Medicine
5.7 DNA Microarray-North America-Other Applications
5.7.1 DNA Microarray-North America-Other Applications, By Geographies
5.7.1.1 DNA Microarray-U.S.-Other Applications
5.7.1.2 DNA Microarray-Canada-Other Applications
5.7.1.3 DNA Microarray-Mexico-Other Applications
5.7.2 DNA Microarray-North America-Other Applications, By Technologies
5.7.2.1 Oligonucleotide Based Gene Chip-North America-Other Applications
5.7.2.2 Complimentary DNA Chips-North America-Other Applications
5.7.3 DNA Microarray-North America-Other Applications, By Products
5.7.3.1 DNA Microarray Instruments-North America-Other Applications
5.7.3.2 DNA Microarray Reagents-North America-Other Applications
5.7.3.3 DNA Microarray Services-North America-Other Applications
6 DNA Microarray-North America, By Products
6.1 Split By Geography
6.2 DNA Microarray-U.S. by Products
6.1 DNA Microarray-Canada by Products
6.1 DNA Microarray-Mexico by Products
6.2 DNA Microarray Instruments-North America
6.2.1 DNA Microarray Instruments-North America, By Geographies
6.2.1.1 DNA Microarray Instruments-U.S.
6.2.1.2 DNA Microarray Instruments-Canada
6.2.1.3 DNA Microarray Instruments-Mexico
6.3 DNA Microarray Reagents-North America
6.3.1 DNA Microarray Reagents-North America, By Geographies
6.3.1.1 DNA Microarray Reagents-U.S.
6.3.1.2 DNA Microarray Reagents-Canada
6.3.1.3 DNA Microarray Reagents-Mexico
6.4 DNA Microarray Services-North America
6.4.1 DNA Microarray Services-North America, By Geographies
6.4.1.1 DNA Microarray Services-U.S.
6.4.1.2 DNA Microarray Services-Canada
6.4.1.3 DNA Microarray Services-Mexico
7 DNA Microarray-North America, By Technologies
7.1 Split By Geography
7.3 DNA Microarray-U.S. by Technologies
7.1 DNA Microarray-Canada by Technologies
7.1 DNA Microarray-Mexico by Technologies
7.2 Oligonucleotide Based Gene Chip-North America
7.2.1 Oligonucleotide Based Gene Chip-North America, By Applications
7.2.1.1 Oligonucleotide Based Gene Chip-North America-In Vitro Diagnostics
7.2.1.2 Oligonucleotide Based Gene Chip-North America-Drug Discovery
7.2.1.3 Oligonucleotide Based Gene Chip-North America-Academics
7.2.1.4 Oligonucleotide Based Gene Chip-North America-Agrigenomics
7.2.1.5 Oligonucleotide Based Gene Chip-North America-Personalized Medicine
7.2.1.6 Oligonucleotide Based Gene Chip-North America-Other Applications
7.2.2 Oligonucleotide Based Gene Chip-North America, By Geographies
7.2.2.1 Oligonucleotide Based Gene Chip-U.S.
7.2.2.2 Oligonucleotide Based Gene Chip-Canada
7.2.2.3 Oligonucleotide Based Gene Chip-Mexico
7.3 Complimentary DNA Chips-North America
7.3.1 Complimentary DNA Chips-North America, By Applications
7.3.1.1 Complimentary DNA Chips-North America-In Vitro Diagnostics
7.3.1.2 Complimentary DNA Chips-North America-Drug Discovery
7.3.1.3 Complimentary DNA Chips-North America-Academics
7.3.1.4 Complimentary DNA Chips-North America-Agrigenomics
7.3.1.5 Complimentary DNA Chips-North America-Personalized Medicine
7.3.1.6 Complimentary DNA Chips-North America-Other Applications
7.3.2 Complimentary DNA Chips-North America, By Geographies
7.3.2.1 Complimentary DNA Chips-U.S.
7.3.2.2 Complimentary DNA Chips-Canada
7.3.2.3 Complimentary DNA Chips-Mexico
8 DNA Microarray-North America, By Geographies
8.1 DNA Microarray-U.S.
8.1.1 DNA Microarray-U.S., By Applications
8.1.1.1 DNA Microarray-U.S.-In Vitro Diagnostics
8.1.1.2 DNA Microarray-U.S.-Drug Discovery
8.1.1.3 DNA Microarray-U.S.-Academics
8.1.1.4 DNA Microarray-U.S.-Agrigenomics
8.1.1.5 DNA Microarray-U.S.-Personalized Medicine
8.1.1.6 DNA Microarray-U.S.-Other Applications
8.1.2 DNA Microarray-U.S., By Technologies
8.1.2.1 Oligonucleotide Based Gene Chip-U.S.
8.1.2.2 Complimentary DNA Chips-U.S.
8.1.3 DNA Microarray-U.S., By Products
8.1.3.1 DNA Microarray Instruments-U.S.
8.1.3.2 DNA Microarray Reagents-U.S.
8.1.3.3 DNA Microarray Services-U.S.
8.2 DNA Microarray-Canada
8.2.1 DNA Microarray-Canada, By Applications
8.2.1.1 DNA Microarray-Canada-In Vitro Diagnostics
8.2.1.2 DNA Microarray-Canada-Drug Discovery
8.2.1.3 DNA Microarray-Canada-Academics
8.2.1.4 DNA Microarray-Canada-Agrigenomics
8.2.1.5 DNA Microarray-Canada-Personalized Medicine
8.2.1.6 DNA Microarray-Canada-Other Applications
8.2.2 DNA Microarray-Canada, By Technologies
8.2.2.1 Oligonucleotide Based Gene Chip-Canada
8.2.2.2 Complimentary DNA Chips-Canada
8.2.3 DNA Microarray-Canada, By Products
8.2.3.1 DNA Microarray Instruments-Canada
8.2.3.2 DNA Microarray Reagents-Canada
8.2.3.3 DNA Microarray Services-Canada
8.3 DNA Microarray-Mexico
8.3.1 DNA Microarray-Mexico, By Applications
8.3.1.1 DNA Microarray-Mexico-In Vitro Diagnostics
8.3.1.2 DNA Microarray-Mexico-Drug Discovery
8.3.1.3 DNA Microarray-Mexico-Academics
8.3.1.4 DNA Microarray-Mexico-Agrigenomics
8.3.1.5 DNA Microarray-Mexico-Personalized Medicine
8.3.1.6 DNA Microarray-Mexico-Other Applications
8.3.2 DNA Microarray-Mexico, By Technologies
8.3.2.1 Oligonucleotide Based Gene Chip-Mexico
8.3.2.2 Complimentary DNA Chips-Mexico
8.3.3 DNA Microarray-Mexico, By Products
8.3.3.1 DNA Microarray Instruments-Mexico
8.3.3.2 DNA Microarray Reagents-Mexico
8.3.3.3 DNA Microarray Services-Mexico
9 DNA Microarray-North America, By Companies
9.1 Competitive landscape
9.2 Split By Geography
9.4 DNA Microarray-U.S. by Companies
9.1 DNA Microarray-Canada by Companies
9.1 DNA Microarray-Mexico by Companies
9.3 DNA Microarray-North America-Other Companies
9.4 DNA Microarray-North America-Affymetrix
9.5 DNA Microarray-North America-Illumina
9.6 DNA Microarray-North America-Agilent Technologies
9.7 DNA Microarray-North America-Roche Diagnostics
9.8 DNA Microarray-North America-Sequenom, Inc.
9.9 DNA Microarray-North America-Bio-Rad Laboratories, Inc.
10 Macro Indicator
11 Global Sub Markets